NotesFAQContact Us
Collection
Advanced
Search Tips
Showing all 2 results Save | Export
Peer reviewed Peer reviewed
Direct linkDirect link
Danov, Stacy E.; Tervo, Raymond; Meyers, Stephanie; Symons, Frank J. – Journal of Mental Health Research in Intellectual Disabilities, 2012
The atypical antipsychotic medication aripiprazole was evaluated using a randomized AB multiple baseline, double-blind, placebo-controlled design for the treatment of severe problem behavior with 4 children with intellectual and developmental disabilities. Functional analysis (FA) was conducted concurrent with the medication evaluation to…
Descriptors: Developmental Disabilities, Rating Scales, Reinforcement, Drug Therapy
Peer reviewed Peer reviewed
Direct linkDirect link
Hale, James B.; Reddy, Linda A.; Semrud-Clikeman, Margaret; Hain, Lisa A.; Whitaker, James; Morley, Jessica; Lawrence, Kyle; Smith, Alex; Jones, Nicole – Journal of Learning Disabilities, 2011
Methylphenidate (MPH) often ameliorates attention-deficit/hyperactivity disorder (ADHD) behavioral dysfunction according to "indirect" informant reports and rating scales. The standard of care behavioral MPH titration approach seldom includes "direct" neuropsychological or academic assessment data to determine treatment…
Descriptors: Academic Achievement, Attention Deficit Hyperactivity Disorder, Rating Scales, Short Term Memory